Skip to main content
. Author manuscript; available in PMC: 2011 Nov 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2010 Sep 20;19(11):2847–2858. doi: 10.1158/1055-9965.EPI-10-0581

Table 5.

Comparison of imputed and observed SNPs in BCL2L11 and risk of NHL subtypes, Mayo Case-Control Study compared with published results from the pooled NCI-SEER, Connecticut, and NSW NHL Case-Control Studies

CLL/SLL
Follicular Lymphoma
DLBCL
SNP ID Major/Minor Ordinal OR p-trend Ordinal OR p-trend Ordinal OR p-trend
Mayo Study (imputed results)
rs7567444 C/T 0.73 (0.53, 1.01) 0.059 0.87 (0.64, 1.20) 0.41 0.91 (0.61, 1.36) 0.64
rs3789068 A/G 1.56 (1.16, 2.10) 0.0032 1.28 (0.95, 1.72) 0.10 1.05 (0.72, 1.52) 0.79
rs686952 C/A 0.74 (0.52, 1.06) 0.097 0.91 (0.65, 1.29) 0.60 1.01 (0.66, 1.54) 0.98
rs6760053 C/G 1.68 (1.15, 2.46) 0.0077 1.31 (0.89, 1.92) 0.17 1.10 (0.68, 1.79) 0.69
Pooled Study (observed results)
rs7567444 C/T 0.93 (0.74, 1.17) 0.54 0.79 (0.68, 0.91) 0.0009 0.91 (0.79, 1.04) 0.15
rs3789068 A/G 1.03 (0.82, 1.29) 0.80 1.28 (1.12, 1.47) 0.0004 1.10 (0.97, 1.26) 0.14
rs686952 C/A 0.93 (0.72, 1.20) 0.56 0.78 (0.67, 0.92) 0.0023 0.87 (0.75, 1.01) 0.078
rs6760053 C/G 1.00 (0.79, 1.26) 0.99 1.19 (1.03, 1.36) 0.015 1.09 (0.95, 1.24) 0.22